Hemu (China) Bioengineering Co.
Latest round
- Series B
Last raised
- Oct 2020
Total raised
- $14M
Investors
- 3
About Hemu (China) Bioengineering Co.
,Ltd. is a company that develops and manufactures medical devices focused on interventional treatment of vascular diseases, and provides overall neuro-intervention solutions for ischemic stroke, hemorrhagic stroke, and intracranial vascular stenosis.
Who invested in Hemu (China) Bioengineering Co.
3 investors across 1 round
See all investors in Hemu (China) Bioengineering Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 20, 2020
Amount
$14M
Investors
Questions about Hemu (China) Bioengineering Co.
Who invested in Hemu (China) Bioengineering Co.?
Hemu (China) Bioengineering Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hemu (China) Bioengineering Co. raised?
Hemu (China) Bioengineering Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hemu (China) Bioengineering Co. last raise money?
Hemu (China) Bioengineering Co.'s most recent round on record is a Series B, in Oct 2020.
What does Hemu (China) Bioengineering Co. do?
Hemu (China) Bioengineering Co. is a medical devices & equipment company.
Where is Hemu (China) Bioengineering Co. headquartered?
Hemu (China) Bioengineering Co. is headquartered in Weihai, China.
Which VCs invest in companies like Hemu (China) Bioengineering Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Hemu (China) Bioengineering Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Hemu (China) Bioengineering Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.